Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants
Clinical trial NCT03315455 · COMPLETED
Trial details
- NCT number
- NCT03315455
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2022-08-03
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.